Skip to main content
BROOKS LABORATORIES LIMITED logo

BROOKS LABORATORIES LIMITED — Investor Relations & Filings

Ticker · BROOKS ISIN · INE650L01011 LEI · 984500FY0879C7971B73 BSE.NS Manufacturing
Open in API
Filings indexed 490 across all filing types
Latest filing 2026-05-22 Regulatory Filings
Country IN India
Listing BSE.NS BROOKS

About BROOKS LABORATORIES LIMITED

https://www.brookslabs.net/

Brooks Laboratories Limited is a pharmaceutical manufacturing enterprise specializing in Contract Research and Manufacturing Services (CRAMS). The company focuses on the production of a diverse range of pharmaceutical formulations, including beta-lactam and non-beta-lactam products. Its portfolio encompasses various dosage forms such as dry powder injections, liquid injections, tablets, and capsules. Key therapeutic segments served include antibiotics, cardiovascular, gastrointestinal, and pain management. The company operates advanced manufacturing facilities designed to meet international quality standards, providing integrated solutions from formulation development to commercial-scale production. Brooks Laboratories emphasizes quality control and regulatory compliance to support its domestic and international client base.

Recent filings

Filing Released Lang Actions
Brooks Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve and take on record the ....
Regulatory Filings Classification · 85% confidence The document is an exchange filing under SEBI Regulation 29 notifying the scheduling of a Board meeting to consider and approve audited financial results. It does not contain the financial results themselves, nor is it a proxy, dividend notice, or AGM material. It is a routine regulatory announcement under continuous disclosure obligations, falling under the catch-all “Regulatory Filings” category.
2026-05-22 English
General Updates
M&A Activity Classification · 90% confidence The document is an official stock exchange filing informing investors that a previously proposed composite scheme of arrangement and amalgamation (a merger by absorption) will not be pursued in its current form. It is a status update on an M&A transaction. Therefore, it falls under M&A Activity (Code: TAR).
2026-05-14 English
Update on Scheme of Arrangement involving Brooks Steriscience Limited ("BSL"), a Joint Venture / Associate of the Company.
M&A Activity Classification · 90% confidence The document is an official stock exchange filing addressed to BSE and NSE notifying an update on a proposed composite scheme of arrangement and amalgamation (i.e., a merger by absorption) between multiple entities and stating that the transaction will not be pursued. This falls squarely under M&A-related announcements. It is not a full financial report, earnings release, board change notice, or dividend declaration. Therefore, it should be classified as M&A Activity (Code: TAR).
2026-05-14 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2026-04-10 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2026-04-08 English
Price movement
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the National Stock Exchange of India regarding a query about unusual movement in the company's share price. It clarifies that the company has disclosed all material information as per regulatory requirements and denies any unpublished price sensitive information. The letter is a compliance communication responding to a regulatory inquiry, not a financial report or announcement of financial results. It does not contain financial data, management changes, voting results, or any other reportable event categories. It is a regulatory filing responding to a surveillance query under SEBI Listing Regulations.
2026-04-02 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.